ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Process Industries

Kaneka Corp.

  • 5,110.00 JPY
  • 0.00
  • 0.00%
  • Japan
    Oct 17, 2018
  • Ticker
  • Prev. close
  • Market cap (JPY)
  • Market cap (USD)
  • Shares

Business Summary

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Chemicals, Functional Plastics, Expandable Plastics and Products, Foodstuffs Products, Life Science Products, Electronic Products, Synthetic Fibers and Others. The Chemicals segment produces polyvinyl chloride (PVC) compounds and PVC-based resins. The Functional Plastics segment offers polymers used in the construction, automotive, consumer electronics, and information equipment industries. The Expandable Plastics and Products segment manufactures and sells cushioning materials for electrical products, shock-absorbing materials for automotive and fishery applications, and expandable plastics and products used in housing insulation. The Foodstuffs Products segment distributes margarine, shortening, and bakery yeast to food sectors. The Life Science Products segment consists of pharmaceutical intermediates, functional food ingredients, catheters, and other medical devices. The Electronic Products segment manufactures functional films and solar cells. The Synthetic Fibers segment engages in the production and sale of synthetic fibers used in wigs, apparel, and other applications. The Others segment provides biopolymers, thermo-resistant and light-resistant transparent resins, organic EL lighting panels, genetic diagnostic products, transdermal medicine, hip protector, fertilizers and biosurfactants. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2018 JPYUSD
Gross Profit163,939M1,479.16M
Operating income36,252M327.08M
Income before tax31,085M280.46M
Net income21,572M194.63M
Diluted EPS328.052.95
Dividends Per Share900.81
Total Assets641,009M6,027.35M
Total liabilities294,408M2,768.29M
Total equity326,487M3,069.92M
Operating cash flow49,750M448.87M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 524,785M 552,189M 555,227M 548,222M 596,142M
Gross Profit 129,334M 135,273M 156,955M 157,992M 163,939M
Operating income 24,821M 24,635M 38,220M 33,165M 36,252M
Income before tax 15,600M 28,174M 30,601M 28,692M 31,085M
Net income 13,650M 18,033M 20,985M 20,484M 21,572M
EBITDA 45,914M 48,885M 65,163M 61,492M 67,104M
Diluted EPS 202.35 267.40 314.60 308.25 328.05
Dividends Per Share 80 80 90 90 90
Total Assets 520,123M 557,962M 577,251M 592,900M 641,009M
Total liabilities 234,990M 248,735M 268,529M 271,346M 294,408M
Total equity 274,547M 298,398M 292,437M 305,421M 326,487M
Operating cash flow 33,924M 33,602M 59,704M 48,119M 49,750M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 5,238.86M 5,026.45M 4,623.64M 5,062.65M 5,378.76M
Gross Profit 1,291.12M 1,231.36M 1,307.04M 1,459.00M 1,479.16M
Operating income 247.78M 224.24M 318.27M 306.26M 327.08M
Income before tax 155.73M 256.46M 254.82M 264.96M 280.46M
Net income 136.26M 164.15M 174.75M 189.16M 194.63M
EBITDA 458.35M 444.98M 542.64M 567.85M 605.45M
Diluted EPS 2.02 2.43 2.61 2.84 2.95
Dividends Per Share 0.79 0.72 0.74 0.83 0.81
Total Assets 5,050.47M 4,652.59M 5,135.91M 5,320.82M 6,027.35M
Total liabilities 2,281.78M 2,074.08M 2,389.15M 2,435.12M 2,768.29M
Total equity 2,665.89M 2,488.20M 2,601.86M 2,740.92M 3,069.92M
Operating cash flow 338.65M 305.87M 497.18M 444.36M 448.87M

Valuation Measures

Mar 2018
Operating margin6.08%
Profit margin3.61%

Key executives

  • President & Representative Director: Mamoru Kadokura
  • Director, Head-Investor & Public Relations: Shinobu Ishihara
  • Representative Director & Vice President: Minoru Tanaka
  • Executive Officer & Manager-IoT Solutions: Yasuhiro Sumi
  • Director & Managing Executive Officer: Hidesuke Amachi


  • Kaneka Corp. (6.2%)
  • Nippon Life Insurance Co. (4.4%)
  • Sumitomo Mitsui Financial Group, Inc. (4.4%)
  • Mitsubishi UFJ Financial Group, Inc. (4.1%)
  • Meiji Yasuda Life Insurance Co. (4.0%)
  • Eastspring Investments (Singapore) Ltd. (3.9%)
  • MS&AD Insurance Group Holdings, Inc. (3.0%)
  • The Vanguard Group, Inc. (2.0%)
  • Nomura Asset Management Co., Ltd. (1.6%)
  • Mitsui & Co., Ltd. (1.5%)

Contact Details

  • Website:
  • Address: Nakanoshima Festival Tower, 35/F, 2-3-18 Nakanoshima, Osaka, 530-8288, Japan
  • Phone: +81.6.6266.5050

Related Companies

  • Kaneka Employee Incentive Plan
  • Kaneka Europe Holding Company NV
  • Kaneka Pharma Vietnam Co. Ltd.
  • Kaneka Taiwan Corp.
  • Kaneka India Pvt Ltd.
  • Kaneka Apical Malaysia Sdn. Bhd.
  • Kaneka (Foshan) Chemical Industries Co. Ltd.
  • Kaneka South America Representative Ltd.
  • PT Kaneka Foods Indonesia
  • Kaneka Korea Corp.
  • Kaneka Singapore Co. (Pte) Ltd.
  • HiHua Fiber Co. Ltd.
  • Kaneka Innovative Fibers Sdn. Bhd.
  • Kaneka Eperan (Suzhou) Co. Ltd.
  • Kaneka Trading (Shanghai) Co. Ltd.
  • River Co., Ltd. (Japan)
  • Kaneka Americas Holding, Inc.
  • GeneFrontier Corp.
  • Tohoku Device Co. Ltd. /Organic El Lighting Device Ops/
  • Kaneka Business Association
  • Kaneka Medix Corp.
  • Hokkaido Kaneka Co. Ltd.
  • Showa Kasei Kogyo Co. Ltd.
  • Kaneka Techno Research Co. Ltd.
  • Kaneka Engineering Corp.
  • Tokai Kaneka Shokuhin Co. Ltd.
  • Tochigi Kaneka Corp.
  • Tatsuta Chemical Co. Ltd.
  • Kaneka Solartech Corp.
  • Tokyo Kaneka Shokuhin Co. Ltd.


  • UBE Industries, Ltd.
  • Westlake Chemical Corporation
  • Innophos Holdings, Inc.
  • Mexichem SAB de CV
  • Shandong Ruifeng Chemical Co., Ltd. Class A
  • Aksa Akrilik Kimya Sanayi A.S.
  • CytoSorbents Corporation
Last Updated on 17 Oct, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media